Literature DB >> 12051261

Methadone: six effects in search of a substance.

Emilie Gomart1.   

Abstract

What is the difference between heroin and methadone? Is this difference one of interpretation, where an 'opiate-like' substance is 'labelled' differently through social processes that arbitrarily describe methadone as 'legal' and 'therapeutic', and heroin as 'illegal' and 'harmful'? To study the nature of this difference, I follow two experiments in the United States and in France of methadone substitution, where medical practices attempt to replace heroin by methadone, and thereby to reduce the user's (illegal) drug use. In these trials, the experimenters ask precisely this question. The question of the nature of the difference between the substance's actions is further illustrated by the comparison between the substitution trials: when the experimenters describe methadone differently in different places and times, do they 'interpret' the drug differently, or is the drug itself different? I show that far too many elements vary from trial to trial to say that the 'interpretation' of the substance is all that varies. In order to explore the variation in detail, then, I draw on works about 'performance', and on the actor-network 'theory of action': what heroin and methadone do, but also also the very way in which they 'pass into action', is what varies in each trial. In the end, this question about difference is a question about action. In each trial, there is not from the start one substance with fixed or vague properties which one can then interpret in various manners. 'Substance' does not contain inherent actions from the start ('properties'). Rather, following the experimenters, it is possible to say that 'effects' are primary and that only at the end of the trial do the experimenters laboriously 'find substance' to effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051261     DOI: 10.1177/0306312702032001005

Source DB:  PubMed          Journal:  Soc Stud Sci        ISSN: 0306-3127            Impact factor:   3.885


  10 in total

1.  Ontological journeys: The lifeworld of opium across the Afghan-Iranian border in/out of the pharmacy.

Authors:  Maziyar Ghiabi
Journal:  Int J Drug Policy       Date:  2021-01-21

2.  Struggling to achieve a 'normal life': A qualitative study of Vietnamese methadone patients.

Authors:  Thu Trang Nguyen; Anh Ngoc Luong; Thi Tuyet Thanh Nham; Carole Chauvin; Jonathan Feelemyer; Nicolas Nagot; Don Des Jarlais; Minh Giang Le; Marie Jauffret-Roustide
Journal:  Int J Drug Policy       Date:  2019-04-09

3.  To Be Free and Normal: Addiction, Governance, and the Therapeutics of Buprenorphine.

Authors:  Shana Harris
Journal:  Med Anthropol Q       Date:  2015-08-18

4.  The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential.

Authors:  Tim Rhodes
Journal:  Soc Sci Med       Date:  2018-02-10       Impact factor: 4.634

5.  From mundane medicines to euphorigenic drugs: How pharmaceutical pleasures are initiated, foregrounded, and made durable.

Authors:  Henry Bundy; Gilbert Quintero
Journal:  Int J Drug Policy       Date:  2017-10-03

6.  What Can the Chemical Hold?: The Politics of Efficacy in the Psychedelic Renaissance.

Authors:  Katherine Hendy
Journal:  Cult Med Psychiatry       Date:  2021-03-02

7.  Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.

Authors:  Joanne Neale; Charlotte N E Tompkins; John Strang
Journal:  Drug Alcohol Rev       Date:  2019-05-26

8.  Studying up harm reduction policy: the office as an assemblage.

Authors:  Jia-Shin Chen
Journal:  Int J Drug Policy       Date:  2011-10-13

9.  Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from 'addiction'.

Authors:  Piera Talin; Emilia Sanabria
Journal:  Int J Drug Policy       Date:  2017-04-19

10.  Polluting pharmaceutical atmospheres: Compulsion, resistance, and symbolism of buprenorphine in Norway.

Authors:  Aleksandra Bartoszko
Journal:  Nordisk Alkohol Nark       Date:  2018-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.